您的位置: 首页 > 农业专利 > 详情页

NOUVEL ANTICORPS DIRIGÉ CONTRE LA PROTÉINE PROGRAMMÉE DE MORT CELLULAIRE (PD-1) ET SON UTILISATION
专利权人:
Y-Biologics Inc.
发明人:
PARK, Jae Eun,KIM, Soo Young,LEE, Hyun Mi,LEE, Si Hyung,LEE, Hyun Kyung,KIM, Hye-Nan,YOUN, Jin Chul,PARK, Bum-chan,LIM, Jung Chae,CHO, Young-Gyu,PARK, Young Woo
申请号:
EP17837299
公开号:
EP3495390A4
申请日:
2017.08.07
申请国别(地区):
EP
年份:
2020
代理人:
摘要:
Disclosed are an antibody to human programmed cell death 1 (PD-1) or an antigen-binding fragment thereof, a nucleic acid encoding the same, a vector including the nucleic acid, an isolated cell transformed with the vector, a method for producing the antibody or an antigen-binding fragment thereof, and a composition for preventing or treating cancer containing the same. The novel antibody binding to PD-1 or an antigen-binding fragment thereof can bind to PD-1 and inhibit the activity of PD-1, thus being useful for the development of immunotherapeutic agents for various diseases associated with PD-1.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充